Bath & Body Works, Inc.

BBWINYSECIK 701985Consumer Cyclical / Specialty Retailfiscal year ends January73 quarters since 2008

Revenue, Q2 FY2027
$1.5B
−2.3% on Q2 FY2026
Net income
$118M
+84.4% on Q2 FY2026
Free cash flow
$23M
+123.2% on Q2 FY2026
Diluted EPS
$0.58
+93.3% on Q2 FY2026
Revenue, TTM
$7.2B
trailing four quarters
Net margin, TTM
10.8%
net income $781M
Free cash flow, TTM
$1.0B
$1.3B less $242M capex
Cash and equivalents
$794M
long-term debt $3.4B, Aug 1, 2026
Shares, 12-month change
−2.2%
202M shares, Aug 1, 2026
Buybacks, TTM
$147M
3.4% of market value
Dividends, TTM
$162M
3.8% of market value
Market value
$4.3B
at the close, buybacks

Latest quarter Q2 FY2027, filed August 26, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2027, the quarter ended August 1, 2026, Bath & Body Works, Inc. reported revenue of $1.5B, −2.3% on Q2 FY2026, and net income of $118M (+84.4%). Operating margin was 14.3%. Free cash flow, operating cash flow less capital expenditures, was $23M ($72M less $49M). Diluted earnings per share were $0.58.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

BBWI daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $21.21 · H $21.50 · L $21.12 · C $21.39 · +1.47% on the dayOver the range: −2.73%, Nov 14, 2025 to Nov 13, 2026
$14$17$20$23$26Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q3 FY2023 to Q2 FY2027, through the filing of August 26, 2026.

Revenue and net incomeRevenueNet income
$0$1B$2B$3BQ3'23, Revenue: $1.6BQ3'23, Net income: $91MQ3'23Q4'23, Revenue: $2.9BQ4'23, Net income: $434MQ4'23Q1'24, Revenue: $1.4BQ1'24, Net income: $81MQ1'24Q2'24, Revenue: $1.6BQ2'24, Net income: $99MQ2'24Q3'24, Revenue: $1.6BQ3'24, Net income: $119MQ3'24Q4'24, Revenue: $2.9BQ4'24, Net income: $579MQ4'24Q1'25, Revenue: $1.4BQ1'25, Net income: $87MQ1'25Q2'25, Revenue: $1.5BQ2'25, Net income: $152MQ2'25Q3'25, Revenue: $1.6BQ3'25, Net income: $106MQ3'25Q4'25, Revenue: $2.8BQ4'25, Net income: $453MQ4'25Q1'26, Revenue: $1.4BQ1'26, Net income: $105MQ1'26Q2'26, Revenue: $1.5BQ2'26, Net income: $64MQ2'26Q3'26, Revenue: $1.6BQ3'26, Net income: $77MQ3'26Q4'26, Revenue: $2.7BQ4'26, Net income: $403MQ4'26Q1'27, Revenue: $1.4BQ1'27, Net income: $183MQ1'27Q2'27, Revenue: $1.5BQ2'27, Net income: $118MQ2'27$0$1B$2B$3BQ3'23, Revenue: $1.6BQ3'23, Net income: $91MQ3'23Q4'23, Revenue: $2.9BQ4'23, Net income: $434MQ4'23Q1'24, Revenue: $1.4BQ1'24, Net income: $81MQ1'24Q2'24, Revenue: $1.6BQ2'24, Net income: $99MQ2'24Q3'24, Revenue: $1.6BQ3'24, Net income: $119MQ3'24Q4'24, Revenue: $2.9BQ4'24, Net income: $579MQ4'24Q1'25, Revenue: $1.4BQ1'25, Net income: $87MQ1'25Q2'25, Revenue: $1.5BQ2'25, Net income: $152MQ2'25Q3'25, Revenue: $1.6BQ3'25, Net income: $106MQ3'25Q4'25, Revenue: $2.8BQ4'25, Net income: $453MQ4'25Q1'26, Revenue: $1.4BQ1'26, Net income: $105MQ1'26Q2'26, Revenue: $1.5BQ2'26, Net income: $64MQ2'26Q3'26, Revenue: $1.6BQ3'26, Net income: $77MQ3'26Q4'26, Revenue: $2.7BQ4'26, Net income: $403MQ4'26Q1'27, Revenue: $1.4BQ1'27, Net income: $183MQ1'27Q2'27, Revenue: $1.5BQ2'27, Net income: $118MQ2'27$0$1B$2B$3BQ3'23, Revenue: $1.6BQ3'23, Net income: $91MQ4'23, Revenue: $2.9BQ4'23, Net income: $434MQ4'23Q1'24, Revenue: $1.4BQ1'24, Net income: $81MQ2'24, Revenue: $1.6BQ2'24, Net income: $99MQ2'24Q3'24, Revenue: $1.6BQ3'24, Net income: $119MQ4'24, Revenue: $2.9BQ4'24, Net income: $579MQ4'24Q1'25, Revenue: $1.4BQ1'25, Net income: $87MQ2'25, Revenue: $1.5BQ2'25, Net income: $152MQ2'25Q3'25, Revenue: $1.6BQ3'25, Net income: $106MQ4'25, Revenue: $2.8BQ4'25, Net income: $453MQ4'25Q1'26, Revenue: $1.4BQ1'26, Net income: $105MQ2'26, Revenue: $1.5BQ2'26, Net income: $64MQ2'26Q3'26, Revenue: $1.6BQ3'26, Net income: $77MQ4'26, Revenue: $2.7BQ4'26, Net income: $403MQ4'26Q1'27, Revenue: $1.4BQ1'27, Net income: $183MQ2'27, Revenue: $1.5BQ2'27, Net income: $118MQ2'27

Net income losses drawn in red.

Free cash flow
−$500M$0$500M$1.0B$1.5BQ3'23, Free cash flow: −$105MQ3'23Q4'23, Free cash flow: $1.0BQ4'23Q1'24, Free cash flow: −$49MQ1'24Q2'24, Free cash flow: −$52MQ2'24Q3'24, Free cash flow: −$121MQ3'24Q4'24, Free cash flow: $878MQ4'24Q1'25, Free cash flow: $30MQ1'25Q2'25, Free cash flow: −$101MQ2'25Q3'25, Free cash flow: −$164MQ3'25Q4'25, Free cash flow: $895MQ4'25Q1'26, Free cash flow: $151MQ1'26Q2'26, Free cash flow: −$99MQ2'26Q3'26, Free cash flow: −$1MQ3'26Q4'26, Free cash flow: $814MQ4'26Q1'27, Free cash flow: $195MQ1'27Q2'27, Free cash flow: $23MQ2'27−$500M$0$500M$1.0B$1.5BQ3'23, Free cash flow: −$105MQ3'23Q4'23, Free cash flow: $1.0BQ4'23Q1'24, Free cash flow: −$49MQ1'24Q2'24, Free cash flow: −$52MQ2'24Q3'24, Free cash flow: −$121MQ3'24Q4'24, Free cash flow: $878MQ4'24Q1'25, Free cash flow: $30MQ1'25Q2'25, Free cash flow: −$101MQ2'25Q3'25, Free cash flow: −$164MQ3'25Q4'25, Free cash flow: $895MQ4'25Q1'26, Free cash flow: $151MQ1'26Q2'26, Free cash flow: −$99MQ2'26Q3'26, Free cash flow: −$1MQ3'26Q4'26, Free cash flow: $814MQ4'26Q1'27, Free cash flow: $195MQ1'27Q2'27, Free cash flow: $23MQ2'27−$500M$0$500M$1.0B$1.5BQ3'23, Free cash flow: −$105MQ4'23, Free cash flow: $1.0BQ4'23Q1'24, Free cash flow: −$49MQ2'24, Free cash flow: −$52MQ2'24Q3'24, Free cash flow: −$121MQ4'24, Free cash flow: $878MQ4'24Q1'25, Free cash flow: $30MQ2'25, Free cash flow: −$101MQ2'25Q3'25, Free cash flow: −$164MQ4'25, Free cash flow: $895MQ4'25Q1'26, Free cash flow: $151MQ2'26, Free cash flow: −$99MQ2'26Q3'26, Free cash flow: −$1MQ4'26, Free cash flow: $814MQ4'26Q1'27, Free cash flow: $195MQ2'27, Free cash flow: $23MQ2'27

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$2B$4B$6BQ3'23, Cash and equivalents: $295MQ3'23, Long-term debt: $4.9BQ3'23Q4'23, Cash and equivalents: $1.2BQ4'23, Long-term debt: $4.9BQ4'23Q1'24, Cash and equivalents: $1.0BQ1'24, Long-term debt: $4.8BQ1'24Q2'24, Cash and equivalents: $790MQ2'24, Long-term debt: $4.7BQ2'24Q3'24, Cash and equivalents: $412MQ3'24, Long-term debt: $4.5BQ3'24Q4'24, Cash and equivalents: $1.1BQ4'24, Long-term debt: $4.4BQ4'24Q1'25, Cash and equivalents: $855MQ1'25, Long-term debt: $4.3BQ1'25Q2'25, Cash and equivalents: $514MQ2'25, Long-term debt: $3.9BQ2'25Q3'25, Cash and equivalents: $191MQ3'25, Long-term debt: $3.9BQ3'25Q4'25, Cash and equivalents: $674MQ4'25, Long-term debt: $3.9BQ4'25Q1'26, Cash and equivalents: $636MQ1'26, Long-term debt: $3.9BQ1'26Q2'26, Cash and equivalents: $364MQ2'26, Long-term debt: $3.9BQ2'26Q3'26, Cash and equivalents: $236MQ3'26, Long-term debt: $3.9BQ3'26Q4'26, Cash and equivalents: $953MQ4'26, Long-term debt: $3.6BQ4'26Q1'27, Cash and equivalents: $820MQ1'27, Long-term debt: $3.6BQ1'27Q2'27, Cash and equivalents: $794MQ2'27, Long-term debt: $3.4BQ2'27$0$2B$4B$6BQ3'23, Cash and equivalents: $295MQ3'23, Long-term debt: $4.9BQ3'23Q4'23, Cash and equivalents: $1.2BQ4'23, Long-term debt: $4.9BQ4'23Q1'24, Cash and equivalents: $1.0BQ1'24, Long-term debt: $4.8BQ1'24Q2'24, Cash and equivalents: $790MQ2'24, Long-term debt: $4.7BQ2'24Q3'24, Cash and equivalents: $412MQ3'24, Long-term debt: $4.5BQ3'24Q4'24, Cash and equivalents: $1.1BQ4'24, Long-term debt: $4.4BQ4'24Q1'25, Cash and equivalents: $855MQ1'25, Long-term debt: $4.3BQ1'25Q2'25, Cash and equivalents: $514MQ2'25, Long-term debt: $3.9BQ2'25Q3'25, Cash and equivalents: $191MQ3'25, Long-term debt: $3.9BQ3'25Q4'25, Cash and equivalents: $674MQ4'25, Long-term debt: $3.9BQ4'25Q1'26, Cash and equivalents: $636MQ1'26, Long-term debt: $3.9BQ1'26Q2'26, Cash and equivalents: $364MQ2'26, Long-term debt: $3.9BQ2'26Q3'26, Cash and equivalents: $236MQ3'26, Long-term debt: $3.9BQ3'26Q4'26, Cash and equivalents: $953MQ4'26, Long-term debt: $3.6BQ4'26Q1'27, Cash and equivalents: $820MQ1'27, Long-term debt: $3.6BQ1'27Q2'27, Cash and equivalents: $794MQ2'27, Long-term debt: $3.4BQ2'27$0$2B$4B$6BQ3'23, Cash and equivalents: $295MQ3'23, Long-term debt: $4.9BQ4'23, Cash and equivalents: $1.2BQ4'23, Long-term debt: $4.9BQ4'23Q1'24, Cash and equivalents: $1.0BQ1'24, Long-term debt: $4.8BQ2'24, Cash and equivalents: $790MQ2'24, Long-term debt: $4.7BQ2'24Q3'24, Cash and equivalents: $412MQ3'24, Long-term debt: $4.5BQ4'24, Cash and equivalents: $1.1BQ4'24, Long-term debt: $4.4BQ4'24Q1'25, Cash and equivalents: $855MQ1'25, Long-term debt: $4.3BQ2'25, Cash and equivalents: $514MQ2'25, Long-term debt: $3.9BQ2'25Q3'25, Cash and equivalents: $191MQ3'25, Long-term debt: $3.9BQ4'25, Cash and equivalents: $674MQ4'25, Long-term debt: $3.9BQ4'25Q1'26, Cash and equivalents: $636MQ1'26, Long-term debt: $3.9BQ2'26, Cash and equivalents: $364MQ2'26, Long-term debt: $3.9BQ2'26Q3'26, Cash and equivalents: $236MQ3'26, Long-term debt: $3.9BQ4'26, Cash and equivalents: $953MQ4'26, Long-term debt: $3.6BQ4'26Q1'27, Cash and equivalents: $820MQ1'27, Long-term debt: $3.6BQ2'27, Cash and equivalents: $794MQ2'27, Long-term debt: $3.4BQ2'27

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2027 filed August 26, 2026.

Bath & Body Works, Inc. income statement, quarterly
Millions of dollarsQ2 FY2027ended Aug 1, 2026filed Aug 26, 2026Q1 FY2027ended May 2, 2026filed May 27, 2026Q4 FY2026ended Jan 31, 2026filed Mar 12, 2026Q3 FY2026ended Nov 1, 2025filed Nov 20, 2025Q2 FY2026ended Aug 2, 2025filed Aug 28, 2025Q1 FY2026ended May 3, 2025filed May 29, 2025Q4 FY2025ended Feb 1, 2025filed Mar 14, 2025Q3 FY2025ended Nov 2, 2024filed Nov 26, 2024YoYQ2 FY2027vs Q2 FY2026
Revenue1,5141,3782,7241,5941,5491,4242,7871,610−2.3%
Cost of revenue8227911,4809369097781,486910−9.6%
Gross profit6925871,2446586406461,301700+8.1%
Research and development—————————
Selling, general and administrative476356645497483437623482−1.4%
Operating income216231599161157209678218+37.6%
Other income (expense)1147106794+83.3%
Pretax income16416653810395146611145+72.6%
Income tax46(17)13526314115839+48.4%
Net income1181834037764105453106+84.4%
Diluted EPS ($)0.580.90—0.370.300.49—0.49+93.3%
Diluted shares (millions)202202—206211215—219—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2027 filed August 26, 2026.

Bath & Body Works, Inc. balance sheet, quarterly
Millions of dollarsQ2 FY2027ended Aug 1, 2026filed Aug 26, 2026Q1 FY2027ended May 2, 2026filed May 27, 2026Q4 FY2026ended Jan 31, 2026filed Mar 12, 2026Q3 FY2026ended Nov 1, 2025filed Nov 20, 2025Q2 FY2026ended Aug 2, 2025filed Aug 28, 2025Q1 FY2026ended May 3, 2025filed May 29, 2025Q4 FY2025ended Feb 1, 2025filed Mar 14, 2025Q3 FY2025ended Nov 2, 2024filed Nov 26, 2024YoYQ2 FY2027vs Q2 FY2026
Cash and equivalents794820953236364636674191+118.1%
Short-term investments—————————
Total current assets2,0501,8992,0191,8811,7061,8201,8231,720+20.2%
Total assets5,1564,9635,0694,9894,8144,8814,8724,984+7.1%
Total current liabilities1,7071,3771,5911,5531,3031,2941,2311,575+31.0%
Long-term debt3,3663,6133,6123,8903,8883,8863,8843,883−13.4%
Total debt3,6143,6133,8923,8903,8883,8863,8844,197−7.0%
Total liabilities—————————
Stockholders’ equity(1,056)(1,133)(1,281)(1,593)(1,548)(1,451)(1,385)(1,749)+31.8%
Shares outstanding (millions)202202201205206212214217—

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2027 filed August 26, 2026.

Bath & Body Works, Inc. cash flow statement, quarterly
Millions of dollarsQ2 FY2027ended Aug 1, 2026filed Aug 26, 2026Q1 FY2027ended May 2, 2026filed May 27, 2026Q4 FY2026ended Jan 31, 2026filed Mar 12, 2026Q3 FY2026ended Nov 1, 2025filed Nov 20, 2025Q2 FY2026ended Aug 2, 2025filed Aug 28, 2025Q1 FY2026ended May 3, 2025filed May 29, 2025Q4 FY2025ended Feb 1, 2025filed Mar 14, 2025Q3 FY2025ended Nov 2, 2024filed Nov 26, 2024YoYQ2 FY2027vs Q2 FY2026
Operating cash flow7224487780(43)188955(99)+267.4%
Capital expenditures4949638156376065−12.5%
Free cash flow (CFO − capex)23195814(1)(99)151895(164)+123.2%
Depreciation and amortization—————————
Share repurchases00579011813652101−100.0%
Dividends paid4040414143424344−7.0%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2026 filed March 12, 2026.

Income statement

Bath & Body Works, Inc. income statement, annual
Millions of dollarsFY2026ended Jan 31, 2026filed Mar 12, 2026FY2025ended Feb 1, 2025filed Mar 14, 2025FY2024ended Feb 3, 2024filed Mar 22, 2024FY2023ended Jan 28, 2023filed Mar 17, 2023FY2022ended Jan 29, 2022filed Mar 18, 2022FY2021ended Jan 30, 2021filed Mar 19, 2021FY2020ended Feb 1, 2020filed Mar 30, 2020FY2019ended Feb 2, 2019filed Mar 22, 2019FY2018ended Feb 3, 2018filed Mar 23, 2018FY2017ended Jan 28, 2017filed Mar 17, 2017FY2016ended Jan 30, 2016filed Mar 18, 2016FY2015ended Jan 31, 2015filed Mar 20, 2015FY2014ended Feb 1, 2014filed Mar 21, 2014FY2013ended Feb 2, 2013filed Mar 22, 2013FY2012ended Jan 28, 2012filed Mar 23, 2012FY2011ended Jan 29, 2011filed Mar 18, 2011FY2010ended Jan 30, 2010filed Mar 26, 2010FY2009ended Jan 31, 2009filed Sep 4, 2009FY2008ended Feb 2, 2008filed Sep 4, 2009
Revenue7,2917,3077,4297,5607,8826,4345,40513,23712,63212,57412,15411,45410,77310,45910,3649,6138,6329,04310,134
Cost of revenue4,1024,0734,1934,3054,0273,3383,0188,3387,6737,4496,9506,6466,3446,0736,3075,9825,6046,0376,625
Gross profit3,1893,2343,2363,2553,8553,0962,3874,8994,9595,1255,2044,8084,4294,3864,0573,6313,0283,0063,509
Research and development———————————————————
Selling, general and administrative2,0631,9681,9511,8791,8461,4921,3473,5633,2313,1223,0122,8552,6862,7202,6982,3412,1662,3112,616
Operating income1,1261,2661,2851,3762,0091,6041,0401,2371,7282,0032,1921,9531,7431,5731,2381,2848685891,110
Other income (expense)32748117(198)(50)(62)5(10)8776717242351751923128
Pretax income8821,0281,0211,0451,4231,1226088571,3121,6961,9341,6361,4461,2811,227————
Income tax233230143251348257148213329538681594543528377446202233411
Net income6497988788001,333844(366)6449831,1581,2531,042903753850805448220718
Diluted EPS ($)3.113.613.843.434.883.00(1.32)2.313.423.984.223.503.052.542.702.421.370.651.89
Diluted shares (millions)209221229233273281278279287291297298296297314333327337—

Balance sheet

Bath & Body Works, Inc. balance sheet, annual
Millions of dollarsFY2026ended Jan 31, 2026filed Mar 12, 2026FY2025ended Feb 1, 2025filed Mar 14, 2025FY2024ended Feb 3, 2024filed Mar 22, 2024FY2023ended Jan 28, 2023filed Mar 17, 2023FY2022ended Jan 29, 2022filed Mar 18, 2022FY2021ended Jan 30, 2021filed Mar 19, 2021FY2020ended Feb 1, 2020filed Mar 30, 2020FY2019ended Feb 2, 2019filed Mar 22, 2019FY2018ended Feb 3, 2018filed Mar 23, 2018FY2017ended Jan 28, 2017filed Mar 17, 2017FY2016ended Jan 30, 2016filed Mar 18, 2016FY2015ended Jan 31, 2015filed Mar 20, 2015FY2014ended Feb 1, 2014filed Mar 21, 2014FY2013ended Feb 2, 2013filed Mar 22, 2013FY2012ended Jan 28, 2012filed Mar 23, 2012FY2011ended Jan 29, 2011filed Mar 18, 2011FY2010ended Jan 30, 2010filed Mar 26, 2010FY2009ended Jan 31, 2009filed Sep 4, 2009FY2008ended Feb 2, 2008filed Sep 4, 2009
Cash and equivalents9536741,0841,2321,9793,5681,4991,4131,5151,9342,5481,6811,6817739351,1301,8041,1731,018
Short-term investments———————————0———————
Total current assets2,0191,8232,1152,2663,0095,5793,2453,2603,2933,4654,1563,1993,1502,2052,3682,5923,2502,867—
Total assets5,0694,8725,4635,4946,02611,57110,1258,0908,1498,1708,4937,4767,1286,0196,1086,4517,1736,972—
Total current liabilities1,5911,2311,2891,3791,2902,8262,3721,9862,0312,0141,8751,6791,8261,5381,5261,5041,3221,255—
Long-term debt3,6123,8844,3884,8624,8546,3665,4875,7395,7075,7005,7154,7224,7614,4773,4812,5072,7232,897—
Total debt3,8923,8844,3884,8624,8546,3665,5485,8115,7945,7365,7214,7654,9764,4773,5382,5072,7272,897—
Total liabilities———————————————————
Stockholders’ equity(1,281)(1,385)(1,627)(2,206)(1,518)(662)(1,499)(869)(753)(729)(259)18(370)(1,015)1371,4762,1831,874—
Shares outstanding (millions)201214225229239279277275279285287292291288319319323——

Cash flow statement

Bath & Body Works, Inc. cash flow statement, annual
Millions of dollarsFY2026ended Jan 31, 2026filed Mar 12, 2026FY2025ended Feb 1, 2025filed Mar 14, 2025FY2024ended Feb 3, 2024filed Mar 22, 2024FY2023ended Jan 28, 2023filed Mar 17, 2023FY2022ended Jan 29, 2022filed Mar 18, 2022FY2021ended Jan 30, 2021filed Mar 19, 2021FY2020ended Feb 1, 2020filed Mar 30, 2020FY2019ended Feb 2, 2019filed Mar 22, 2019FY2018ended Feb 3, 2018filed Mar 23, 2018FY2017ended Jan 28, 2017filed Mar 17, 2017FY2016ended Jan 30, 2016filed Mar 18, 2016FY2015ended Jan 31, 2015filed Mar 20, 2015FY2014ended Feb 1, 2014filed Mar 21, 2014FY2013ended Feb 2, 2013filed Mar 22, 2013FY2012ended Jan 28, 2012filed Mar 23, 2012FY2011ended Jan 29, 2011filed Mar 18, 2011FY2010ended Jan 30, 2010filed Mar 26, 2010FY2009ended Jan 31, 2009filed Sep 4, 2009FY2008ended Feb 2, 2008filed Sep 4, 2009
Operating cash flow1,1028869541,1441,4922,0391,2361,3771,4061,9902,0271,7861,2481,3511,2661,2841,174954765
Capital expenditures237226298328270228458629707990727715691588426274202479749
Free cash flow (CFO − capex)8656606568161,2221,8117787486991,0001,3001,0715577638401,01097247516
Depreciation and amortization—————521588547524472415398368354356359357377385
Share repurchases4014011481,3121,9640019844643548387606291,19020703791,402
Dividends paid167177182186120833326666861,2681,1716913491,4491,1441,488193201227

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$14
1 sales by 1 insider; officers and directors $14
Bought, twelve months
$1M
6 purchases by 6 insiders; officers and directors $1M
Sold, twelve months
$14
1 sales by 1 insider; officers and directors $14

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Nov 10, 2026Javitch TomInterim CFOaward11,547$0.00—70,550Nov 12, 2026
Oct 16, 2026Nash Sarah EDirectoropen-market sale1$20.57$14299,101Oct 20, 2026
Aug 10, 2026Aber AnnChief Legal Officer &Corp Secyaward12,940$0.00—12,940Aug 12, 2026
Jun 12, 2026Javitch TomInterim CFOaward10,309$0.00—59,003Jun 15, 2026
Jun 11, 2026Voskuil Steven EDirectoraward7,970$0.00—41,895Jun 15, 2026
Jun 11, 2026Rajlin JuanDirectoraward7,970$0.00—24,490Jun 15, 2026
Jun 11, 2026Symancyk James KevinDirectoraward7,970$0.00—48,349Jun 15, 2026
Jun 11, 2026Lee Danielle M.Directoraward7,970$0.00—26,181Jun 15, 2026
Jun 11, 2026Steinour Stephen DDirectoraward7,970$0.00—56,145Jun 15, 2026
Jun 11, 2026Hondal FrancisDirectoraward7,970$0.00—13,611Jun 15, 2026
Jun 11, 2026Nash Sarah EDirectoraward13,284$0.00—298,895Jun 15, 2026
Jun 11, 2026Brady LucyDirectoraward7,970$0.00—25,452Jun 15, 2026
Jun 11, 2026Bogliolo AlessandroDirectoraward7,970$0.00—24,490Jun 15, 2026
May 19, 2026Mazurek Thomas E.Chief Supply Chain Officeraward6,616$0.00—119,297May 20, 2026
May 19, 2026Mazurek Thomas E.Chief Supply Chain Officertax withholding4,127$16.11$66K115,170May 20, 2026
May 16, 2026Heaf DanielCEO, Directortax withholding7,334$17.09$125K288,249May 19, 2026
Mar 13, 2026Mazurek Thomas E.Chief Supply Chain Officertax withholding6,327$19.50$123K112,681Mar 16, 2026
Mar 13, 2026Boratto Eva CChief Financial Officertax withholding10,782$19.50$210K223,459Mar 16, 2026
Mar 12, 2026Heaf DanielCEO, Directoraward212,993$0.00—295,583Mar 16, 2026
Mar 12, 2026Mazurek Thomas E.Chief Supply Chain Officeraward40,921$0.00—118,654Mar 16, 2026
Mar 12, 2026Boratto Eva CChief Financial Officeraward115,815$0.00—234,241Mar 16, 2026
Nov 24, 2025Symancyk James KevinDirectoropen-market buy22,500$15.58$351K40,379Nov 25, 2025
Nov 24, 2025Nash Sarah EDirectoropen-market buy10,000$15.58$156K285,522Nov 25, 2025
Nov 21, 2025Voskuil Steven EDirectoropen-market buy20,000$15.04$301K33,925Nov 24, 2025
Nov 21, 2025Steinour Stephen DDirectoropen-market buy6,700$14.86$100K48,175Nov 24, 2025

Full insider history for Bath & Body Works, Inc., or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held BBWI in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded BBWI by quarter.

FundManagerQuarterValueSharesWeightMove
Renaissance TechnologiesPeter BrownQ3 2026$59M4M0.08%trimmed −7.6%

Sources

Fiscal year ends in month 1; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
BATH & BODY WORKS, INC., CIK 701985 on EDGAR
Extract generated
November 16, 2026
Withheld
7 line-years whose four quarters do not sum to the filed year: gross profit FY2020, operating income FY2020, pretax income FY2020, revenue FY2020, cost of revenue FY2021, income tax FY2021, opex sga FY2021
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: not filed
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total debt: LongTermDebt, combined, noncurrent, noncurrent+current
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAmortizationAndAccretionNet, DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/BBWI.json